(Q43796412)

English

The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?

scientific article published in November 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology? (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Koudinov AR

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Berezov TT

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Koudinova NV

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

1 November 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Neuroscience Letters

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

314

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

115-118

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Cholinergic stimulation of hippocampal pyramidal cells is inhibited by increasing membrane cholesterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alzheimer's amyloid beta and lipid metabolism: a missing link?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

HDL phospholipid: a natural inhibitor of Alzheimer's amyloid beta-fibrillogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoproteins in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

High-density lipoprotein cholesterol in differential diagnosis of senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Uptake of lipoproteins for axonal growth of sympathetic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902263-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0304-3940(01)02263-7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43796412&oldid=2103411330"